Near infrared/ red light therapy a potential countermeasure for mitochondrial dysfunction in spaceflight associated neuro-ocular syndrome (SANS) | Eye

Eye volume 38, pages 2499–2501 (2024)Cite this article

5057 Accesses

37 Altmetric

Metrics details

Spaceflight-associated neuro-ocular syndrome (SANS) is a syndrome know to affect a significant proportion of astronauts during long-duration spaceflight (LDSF). SANS is characterized by optic disc edema [1], hyperopic shifts [2], chorioretinal folds [3] and globe flattening [4]. While the precise etiology of SANS remains incompletely understood, it is hypothesized to be as a result of the unique conditions encountered in the microgravity environment characteristic of LDSF, and heightened radiation exposure [5]. So far, SANS has been associated with alterations in fluid distribution and ocular structural adaptations induced by microgravity conditions [5].

The effects of microgravity and heightened exposure to radiation through galactic cosmic radiation and solar particle events during space missions are recognized in part for their notable influences on mitochondrial function [6]. Recent comprehensive analyses utilizing multi-omics revealed a consistent manifestation of mitochondrial stress during spaceflight [7]. These alterations include disturbances in metabolic pathways and gene regulation, and suggest that mitochondrial dysfunction plays an important role in prolonged space missions and SANS [7]. Oxidative stress emerges from an imbalance between reactive oxygen species (ROS) production and cellular antioxidant capacity [8]. Mitochondria act as both generators and receivers of ROS, and thus any impairment in their function may potentially contribute to the oxidative stress evident in SANS [8].

Retinal photoreceptors have an abundance of mitochondria to enable phagocytosis and outer segment renewal [9]. Retinal ganglion cell axons also have highly concentrations of mitochondria to efficiently transmit visual information from the eye to the brain. Unlike most cell types, neurons have absolute levels of mitochondrial function requirements to survive due to membrane potential generation requirements [10]. Further understanding the possible role of mitochondrial dysfunction in SANS is essential to develop countermeasures to mitigate the ophthalmic risks associated with long-duration spaceflight [11]. Current proposed countermeasures for SANS include intraocular pressure increase with swimming goggles [12], and vision enhancement with augmented reality to restore any visual losses that may occur [13, 14], however these current countermeasures are insufficient at addressing the underlying pathophysiology of SANS.

Red/Near Infrared (NIR) Light Therapy may serve as a non-invasive and side-effect-free countermeasure to improve mitochondrial function during LDSF. NIR/red light therapy is a form of phototherapy that utilizes specific wavelengths of light to promote healing and reduce inflammation [15, 16]. NIR/red light therapy is believed to enhance mitochondrial function via the absorption of photons by mitochondrial chromophores, such as cytochrome c oxidase, contributing to improved cellular respiration and ATP production, and reducing ROS generation [17]. NIR/red light also has known anti-inflammatory properties, which could mitigate inflammation associated with SANS and its impact on ocular tissues [17]. Furthermore, secondary effects can also occur hours following NIR/red light exposure including the dissociation of nitric oxide from its binding site, modification of the ATP pool and an increased mitochondrial intermembrane potential (Fig. 1) [18]. Alterations in ATP levels can affect cyclic adenosine monophosphate levels, intracellular calcium levels and cellular metabolism.

These beneficial effects may potentially be useful to mitigate the symptoms of spaceflight associated neuro-ocular syndrome.

NIR/red light therapy has previously been shown to have potential in treating a wide variety of ophthalmic diseases that have a mitochondrial dysfunction component, such as: age related macular degeneration [19], diabetic macular edema [20], myopia [21], dry eye disease [22] and retinitis pigmentosa [23]. NIR/red light therapy has also been shown to improve the normal decline in mitochondrial function that is associated with aging, with a recent study finding improved contrast sensitivity for the tritan axis in participants aged 40-years-old and above treated with 670 nm light [24]. Another study conducted on healthy participants aged 55 years-and-older found that treatment with 670 nm light led to significant improvements in scotopic thresholds, but did not significantly alter visual acuity, low luminance visual acuity, rod-intercept time and no structural alterations on OCT [25].

While promising, the efficacy of red/NIR light therapy for SANS requires further investigation. Many of the existing studies involve smaller sample sizes and several of these studies lack control groups. Factors such as optimal light parameters, treatment duration, and long-term effects need to be carefully evaluated in order to develop standardized protocols for space missions. Moreover, integrating red/NIR light therapy into the comprehensive management of SANS alongside other interventions may offer a synergistic approach to mitigating ocular complications in astronauts. Finally, further research is required to fully understand the subtle functional and structural changes that occur in the eye during LDSF, to fully understand how to mitigate these effects [26, 27].

Waisberg E, Ong J, Lee AG. Factors associated with optic disc edema development during spaceflight. JAMA Ophthalmol. 2023. https://doi.org/10.1001/jamaophthalmol.2023.0303.

Article PubMed Google Scholar

Ong J, Waisberg E, Masalkhi M, Kamran SA, Lowry K, Sarker P, et al. Artificial intelligence frameworks to detect and investigate the pathophysiology of spaceflight associated neuro-ocular syndrome (SANS). Brain Sci. 2023;13:1148. https://doi.org/10.3390/brainsci13081148.

Article PubMed PubMed Central Google Scholar

Masalkhi M, Ong J, Waisberg E, Lee AG. Chorioretinal folds in astronauts: risk of chorioretinal fold-related maculopathy and terrestrial staging of disease. Eye. 2023. https://doi.org/10.1038/s41433-023-02730-6.

Article PubMed PubMed Central Google Scholar

Soares B, Ong J, Osteicoechea D, Kadipasaoglu CM, Waisberg E, Sarker P, et al. A potential compensatory mechanism for spaceflight associated neuro-ocular changes from microgravity: current understanding and future directions. Eye. 2024:s41433-024-02952-2. https://doi.org/10.1038/s41433-024-02952-2.

Lee AG, Mader TH, Gibson CR, et al. Spaceflight associated neuro-ocular syndrome (SANS) and the neuro-ophthalmologic effects of microgravity: a review and an update. npj Microgravity. 2020;6:1–10. https://doi.org/10.1038/s41526-020-0097-9.

Article Google Scholar

Nguyen HP, Tran PH, Kim KS, Yang SG. The effects of real and simulated microgravity on cellular mitochondrial function. npj Microgravity. 2021;7:44. https://doi.org/10.1038/s41526-021-00171-7.

Article PubMed PubMed Central CAS Google Scholar

Da Silveira WA, Fazelinia H, Rosenthal SB, Laiakis EC, Kim MS, Meydan C, et al. Comprehensive multi-omics analysis reveals mitochondrial stress as a central biological hub for spaceflight impact. Cell. 2020;183:1185–1201.e20. https://doi.org/10.1016/j.cell.2020.11.002.

Article PubMed PubMed Central CAS Google Scholar

Ocular oxidative changes and antioxidant therapy during spaceflight | Eye. Accessed November 30, 2023. https://www.nature.com/articles/s41433-023-02841-0.

Wang J, Deretic D. Molecular complexes that direct rhodopsin transport to primary cilia. Prog Retinal Eye Res. 2014;38:1–19. https://doi.org/10.1016/j.preteyeres.2013.08.004.

Article CAS Google Scholar

Osborne NN, Álvarez CN, Del Olmo Aguado S. Targeting mitochondrial dysfunction as in aging and glaucoma. Drug Discov Today. 2014;19:1613–22. https://doi.org/10.1016/j.drudis.2014.05.010.

Article PubMed CAS Google Scholar

Waisberg E, Ong J, Masalkhi M, Mao XW, Beheshti A, Lee AG. Mitochondrial dysfunction in Spaceflight Associated Neuro-Ocular Syndrome (SANS): a molecular hypothesis in pathogenesis. Eye. 2024. https://doi.org/10.1038/s41433-024-02951-3.

Article PubMed PubMed Central Google Scholar

Waisberg E, Ong J, Masalkhi M, Paladugu P, Lee AG, Berdahl J. Precisional modulation of translaminar pressure gradients for ophthalmic diseases. Eur J Ophthalmol. 2023:11206721231199779. https://doi.org/10.1177/11206721231199779.

Ong J, Zaman N, Waisberg E, Kamran SA, Lee AG, Tavakkoli A. Head-mounted digital metamorphopsia suppression as a countermeasure for macular-related visual distortions for prolonged spaceflight missions and terrestrial health. Wearable Technol. 2022;3:e26. https://doi.org/10.1017/wtc.2022.21.

Article PubMed PubMed Central Google Scholar

Waisberg E, Ong J, Zaman N, Paladugu P, Kamran SA, Tavakkoli A, et al. The spaceflight contrast sensitivity hypothesis and its role to investigate the pathophysiology of spaceflight-associated neuro-ocular syndrome. Front Ophthalmol. 2023;3:1229748. https://doi.org/10.3389/fopht.2023.1229748.

Article Google Scholar

Tsai SR, Hamblin MR. Biological effects and medical applications of infrared radiation. J Photochem Photobiol B: Biol. 2017;170:197–207. https://doi.org/10.1016/j.jphotobiol.2017.04.014.

Article CAS Google Scholar

The role of near-infrared light-emitting diodes in aging adults related to inflammation. Healthy Aging Res. https://doi.org/10.12715/har.2015.4.24.

Arranz-Paraíso D, Sola Y, Baeza-Moyano D, Benítez-Martínez M, Melero-Tur S, González-Lezcano RA. Mitochondria and light: An overview of the pathways triggered in skin and retina with incident infrared radiation. J Photochem Photobiol B: Biol. 2023;238:112614. https://doi.org/10.1016/j.jphotobiol.2022.112614.

Article CAS Google Scholar

Gonzalez-Lima F, Rojas. Low-level light therapy of the eye and brain. EB. Published online October 2011:49. https://doi.org/10.2147/EB.S21391.

Burton B, Parodi MB, Jürgens I, Zanlonghi X, Hornan D, Roider J, et al. LIGHTSITE II randomized multicenter trial: evaluation of multiwavelength photobiomodulation in non-exudative age-related macular degeneration. Ophthalmol Ther. 2023;12:953–68. https://doi.org/10.1007/s40123-022-00640-6.

Article PubMed PubMed Central Google Scholar

Tang J, Herda AA, Kern TS. Photobiomodulation in the treatment of patients with non-center-involving diabetic macular oedema. Br J Ophthalmol. 2014;98:1013–5. https://doi.org/10.1136/bjophthalmol-2013-304477.

Article PubMed Google Scholar

Jiang Y, Zhu Z, Tan X, Kong X, Zhong H, Zhang J, et al. Effect of repeated low-level red-light therapy for myopia control in children. Ophthalmology. 2022;129:509–19. https://doi.org/10.1016/j.ophtha.2021.11.023.

Article PubMed Google Scholar

Giannaccare G, Vaccaro S, Pellegrini M, Borselli M, Carnovale Scalzo G, Taloni A, et al. Serial sessions of a novel low-level light therapy device for home treatment of dry eye disease. Ophthalmol Ther. 2023;12:459–68. https://doi.org/10.1007/s40123-022-00619-3.

Article PubMed Google Scholar

Ivandic BT, Ivandic T. Low-level laser therapy improves vision in a patient with retinitis pigmentosa. Photomed Laser Surg. 2014;32:181–4. https://doi.org/10.1089/pho.2013.3535.

Article PubMed Google Scholar

Shinhmar H, Grewal M, Sivaprasad S, Hogg C, Chong V, Neveu M, et al. Optically improved mitochondrial function redeems aged human visual decline. Le Couteur D, ed. J Gerontology: Ser A. 2020;75:e49–e52. https://doi.org/10.1093/gerona/glaa155.

Article CAS Google Scholar

Grewal MK, Sivapathasuntharam C, Chandra S, Gurudas S, Chong V, Bird A, et al. A pilot study evaluating the effects of 670 nm photobiomodulation in healthy ageing and age-related macular degeneration. JCM. 2020;9:1001. https://doi.org/10.3390/jcm9041001.

Article PubMed PubMed Central Google Scholar

Masalkhi M, Ong J, Waisberg E, Lee AG. Deep learning in ophthalmic and orbital ultrasound for spaceflight associated neuro-ocular syndrome (SANS). Eye. 2023. https://doi.org/10.1038/s41433-023-02877-2.

Article PubMed PubMed Central Google Scholar

Waisberg E, Ong J, Masalkhi M, Lee AG. Anemia and spaceflight associated neuro-ocular syndrome (SANS). Prehosp Disaster Med. Published online July 31, 2023:1-3. https://doi.org/10.1017/S1049023X23006131.

Download references

Department of Ophthalmology, University of Cambridge, Cambridge, UK

Ethan Waisberg

Department of Ophthalmology and Visual Sciences, University of Michigan Kellogg Eye Center, Ann Arbor, MI, USA

Joshua Ong

School of Medicine, University College Dublin, Dublin, Ireland

Mouayad Masalkhi

Department of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, USA

Andrew G. Lee

The Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, USA

Andrew G. Lee

Departments of Ophthalmology, Neurology, and Neurosurgery, Weill Cornell Medicine, New York, NY, USA

Andrew G. Lee

Department of Ophthalmology, University of Texas Medical Branch, Galveston, TX, USA

Andrew G. Lee

University of Texas MD Anderson Cancer Center, Houston, TX, USA

Andrew G. Lee

Texas A&M College of Medicine, Houston, TX, USA

Andrew G. Lee

Department of Ophthalmology, The University of Iowa Hospitals and Clinics, Iowa City, IA, USA

Andrew G. Lee

You can also search for this author in PubMed Google Scholar

You can also search for this author in PubMed Google Scholar

You can also search for this author in PubMed Google Scholar

You can also search for this author in PubMed Google Scholar

EW—Conceptualization, Writing. JO—Conceptualization, Writing. MM—Conceptualization, Writing. AGL—Review, Intellectual Support.

Correspondence to Ethan Waisberg.

The authors declare no competing interests.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

Waisberg, E., Ong, J., Masalkhi, M. et al. Near infrared/ red light therapy a potential countermeasure for mitochondrial dysfunction in spaceflight associated neuro-ocular syndrome (SANS). Eye 38, 2499–2501 (2024). https://doi.org/10.1038/s41433-024-03091-4

Download citation

Received: 12 March 2024

Revised: 05 April 2024

Accepted: 12 April 2024

Published: 03 May 2024

Issue Date: September 2024

DOI: https://doi.org/10.1038/s41433-024-03091-4

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative